Suppr超能文献

减少抗抑郁药使用的策略。

Strategies to reduce use of antidepressants.

机构信息

Primary Care, Population Sciences & Medical Education, University of Southampton, Aldermoor Health Centre, Southampton, UK.

出版信息

Br J Clin Pharmacol. 2021 Jan;87(1):23-33. doi: 10.1111/bcp.14475. Epub 2020 Jul 27.

Abstract

Antidepressant prescribing has increased year on year since the introduction of the selective serotonin reuptake inhibitors (SSRIs) in the 1980s. More than 10% of adults in England are now taking antidepressants for depression/anxiety, with a median length of treatment of more than 2 years, but antidepressants can cause side effects and withdrawal symptoms which increase with longer use. Surveys of antidepressant users suggest 30-50% have no evidence-based indication to continue, but coming off antidepressants is often difficult due to fears of relapse, withdrawal symptoms and a lack of psychological treatments to replace maintenance treatment and prevent relapse. GPs should not prescribe antidepressants routinely for mild depressive/anxiety symptoms. Patients starting antidepressants should be advised that they are to be taken for a limited period only, and that there is a risk of withdrawal problems on stopping them. Prescribers should actively review long-term antidepressant use and suggest coming off them slowly to patients who are well. The relationship between SSRI dose and serotonin transporter receptor occupancy suggests that hyperbolic tapering regimes may be helpful for patients with troubling withdrawal symptoms who cannot stop treatment within 4-8 weeks, and tapering strips can allow carefully titrated slower dose reduction over some months. Internet and telephone support to patients wanting to reduce their antidepressants is being trialled in the REDUCE programme. More research is needed to establish the incidence of withdrawal symptoms in representative samples of patients coming off antidepressants, and large randomised controlled trials are needed to test different tapering strategies.

摘要

自 20 世纪 80 年代选择性 5-羟色胺再摄取抑制剂 (SSRIs) 问世以来,抗抑郁药的处方量逐年增加。现在,英格兰超过 10%的成年人因抑郁/焦虑而服用抗抑郁药,平均治疗时间超过 2 年,但抗抑郁药可能会产生副作用和戒断症状,且随着使用时间的延长而增加。对抗抑郁药使用者的调查表明,有 30-50%的人没有继续使用的基于证据的指征,但由于担心复发、戒断症状和缺乏心理治疗来替代维持治疗和预防复发,停药往往很困难。全科医生不应常规为轻度抑郁/焦虑症状开抗抑郁药。开始服用抗抑郁药的患者应被告知,他们只应在有限的时间内服用,并且停药后可能会出现戒断问题。对于病情良好的患者,处方者应积极审查长期使用抗抑郁药的情况,并建议缓慢停药。SSRI 剂量与 5-羟色胺转运体受体占有率之间的关系表明,双曲线逐渐减量方案可能对那些无法在 4-8 周内停止治疗且有困扰性戒断症状的患者有帮助,而逐渐减量条可以在几个月内仔细调整较慢的剂量减少。在 REDUCE 计划中,正在对想要减少抗抑郁药剂量的患者进行互联网和电话支持的试验。需要进行更多的研究,以确定在停药的代表性患者样本中戒断症状的发生率,并且需要进行大型随机对照试验来测试不同的逐渐减量策略。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验